INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.53B 3.02M 822.2K 4.16M
Cost of Revenue
3.66B 1.93M 331.52K 145.05K
Gross Profit
2.87B 1.09M 490.67K 4.02M
Operating Income
-8.13B -6.77M -10.63M -5.22M
Interest Income
n/a n/a 308.00 3.66K
Pretax Income
-9.12B -8.01M -10.89M -6.65M
Net Income
-9.35B -8.03M -10.89M -6.65M
Selling & General & Admin
9.08B 7.49M 10.57M 9.02M
Research & Development
489.66M 165.94K 544.04K 216.43K
Other Expenses
1.43B 200.89K n/a n/a
Operating Expenses
11B 7.85M 11.12M 9.23M
Interest Expense
-1.06B 925.91K 59.45K 1.27M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
14.66B 9.79M 11.45M 9.38M
Income Tax Expense
-22.91M 27.79K 2.87K 4.76K
Shares Outstanding (Basic)
3.1M 1.57M 606.13K 531.62K
Shares Outstanding (Diluted)
3.1M 1.57M 606.13K 531.62K
EPS (Basic)
-3.02K -5.13 -17.97 -12.52
EPS (Diluted)
-3.02K -5.13 -17.97 -12.52
EBITDA
-9.51B -6.88M -10.52M -5.22M
EBIT
n/a -7.08M -10.83M -5.38M
Depreciation & Amortization
919.6M 200.89K 306.32K 166.08K